FDA Releases Draft Guidance on Threshold Analyses and Human Factors Submissions

In new draft guidance issued Friday, the FDA outlined what it expects sponsors to include in submissions of use-related risk analyses, threshold analyses, comparative use human factors (HF) and HF validation study protocols and reports.
Source: Drug Industry Daily